Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › SGMT
SILVERARC CAPITAL MANAGEMENT, LLC position in SGMT
SAGIMET BIOSCIENCES INC · Health Care
SILVERARC CAPITAL MANAGEMENT, LLC reported holding 3,745,990 shares of SGMT (SAGIMET BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$37.0M, representing 4.72% of its reported portfolio and ranking #6 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed SGMT holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SILVERARC CAPITAL MANAGEMENT, LLC's SGMT position evolved
SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in SGMT in Q3 2023 at 100,000 shares (US$880K). The position peaked in Q3 2026 at 3,745,990 shares, worth US$37.0M. Across 4 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,745,990 shares valued at US$37.0M — an increase of 818,292 shares quarter over quarter.. Notable position changes include a 28% increase in Q3 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 100.00K | $880.00K | New |
| Q2 2025 | 37.54K | $286.05K | New |
| Q2 2026 | 2.93M | $22.63M | New |
| Q3 2026 | 3.75M | $37.01M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SGMT and 13F data
SGMT (SAGIMET BIOSCIENCES INC) is a Health Care company. 58 other funds we track also report a position in SGMT — the largest reported positions include BVF INC/IL (US$19.3M), Caligan Partners LP (US$19.3M), Affinity Asset Advisors, LLC (US$19.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SGMT
- BVF INC/IL 2.50M sh · $19.32M · Q2 2026
- Caligan Partners LP 2.50M sh · $19.32M · Q2 2026
- Affinity Asset Advisors, LLC 2.50M sh · $19.31M · Q2 2026
- GREAT POINT PARTNERS LLC 2.03M sh · $15.69M · Q2 2026
- Saturn V Capital Management LP 1.48M sh · $11.44M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 724.80K sh · $5.60M · Q2 2026
- Jones Hill Capital LP 502.59K sh · $4.97M · Q3 2026
- Seven Fleet Capital Management LP 403.55K sh · $3.12M · Q2 2026
- Palo Alto Investors LP 250.00K sh · $1.93M · Q2 2026
- Pale Fire Capital SE 221.88K sh · $1.72M · Q2 2026
- Sofinnova Investments, Inc. 166.67K sh · $1.29M · Q2 2026
- ACT Capital Partners, L.P. 60.00K sh · $592.80K · Q3 2026
More on SILVERARC CAPITAL MANAGEMENT, LLC
FAQ
How long has SILVERARC CAPITAL MANAGEMENT, LLC held SGMT?
SILVERARC CAPITAL MANAGEMENT, LLC has disclosed SGMT holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in SGMT?
As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 3.75M shares of SGMT (SAGIMET BIOSCIENCES INC), valued at $37.01M, representing 4.72% of its reported portfolio and ranking #6.
Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling SGMT?
In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in SGMT. The position peaked in Q3 2026 at 3.75M shares.
Which other funds hold SGMT?
Other major institutional holders of SGMT include BVF INC/IL, Caligan Partners LP, Affinity Asset Advisors, LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.